
COA 2022: Surgical Resection Type and Adjuvant Therapies on Survival of Primary Spine Sarcomas
How to Cite
OrthoEvidence. COA 2022: Surgical Resection Type and Adjuvant Therapies on Survival of Primary Spine Sarcomas. ACE Report. 2022;255(3):35. Available from: https://myorthoevidence.com/AceReport/Report/14726
Primary sarcomas of the spine: a systematic review and pooled data
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Eleven studies including 150 spinal sarcoma patients were included in this meta-analysis assessing the effect of surgical resection types and adjuvant therapies on patient survival. The outcomes of interest included overall mortality/survival and local recurrence. Significantly greater overall survival was observed with en-bloc resection vs. piecemeal resection for spine chondrosarcomas and Ewing ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!


Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.